Related Experiment Video
Updated: Dec 24, 2025

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
Published on: October 16, 2021
Optimal versus suboptimal mitral valve repair: late results in a matched cohort study
Michele De Bonis1,2, Edoardo Zancanaro2, Elisabetta Lapenna2
1School of Medicine, Vita-Salute San Raffaele University, Milan, Italy.
Objectives:
After mitral repair for degenerative mitral regurgitation (MR), no or mild (≤1+/4+) residual MR should remain. Occasionally patients are left with more than mild residual MR (>1+/4+) for a number of reasons. The aim of this study was to assess the late implications of such a suboptimal repair in a matched cohort study.
Methods:
From 2006 to 2013, a total of 2158 patients underwent mitral repair for degenerative MR in our institution. Fifty patients (2.3%) with residual MR >1+ at hospital discharge (study group) were matched up to 1:2 with 91 patients operated on during the same period who were discharged with MR ≤1+ (control group). The median follow-up was 8 years (interquartile range 6.3-10.1, longest 12.7 years). A comparative analysis of the outcomes in the 2 groups was performed.
Results:
Overall survival at 8 years was 87 ± 8% in the study group and 92 ± 3% in the control group (P = 0.23). There were 3 late deaths (6.0%) in the study group and 6 deaths (6.6%) in the control group. Freedom from reoperation was similar (P = 1.0). At 8 years the prevalence of MR ≥3+ was significantly higher in the study group (15.6% vs 2.1%, P < 0.001) as was the use of diuretics, beta-blockers and angiotensin-converting enzyme inhibitors/angiotensin-receptor blockers. Interestingly, even in the control group, a gradual progression of MR was observed because 13.3% of the patients had MR ≥2+ at 8 years with a significant increase over time (P < 0.001).
Conclusions:
Residual MR more than mild at hospital discharge is associated with lower durability of mitral repair and the need for more medical therapy in the long term. However, even an initial optimal result does not completely arrest the progression of the degenerative process.
Insights
Suboptimal mitral repair for degenerative mitral regurgitation (MR) leads to lower durability and increased need for medication. Even optimal repairs do not halt MR progression, highlighting the chronic nature of the condition.
Area of Science:
- Cardiovascular Surgery
- Cardiac Surgery Outcomes
- Mitral Valve Repair
Background:
- Degenerative mitral regurgitation (MR) requires repair, with ideal outcomes aiming for no or mild residual MR (≤1+/4+).
- Occasionally, patients have more than mild residual MR (>1+/4+) after mitral repair due to various factors.
- Assessing the long-term consequences of suboptimal mitral repair is crucial for patient management.
Purpose of the Study:
- To evaluate the late implications of mitral repair resulting in more than mild residual MR.
- To compare outcomes between patients with suboptimal repair and those with optimal repair (≤1+ MR).
Main Methods:
- A matched cohort study included 50 patients with residual MR >1+ (study group) and 91 patients with MR ≤1+ (control group).
- Patients underwent mitral repair for degenerative MR between 2006 and 2013.
- Median follow-up was 8 years, with comparative analysis of survival, reoperation, and MR progression.
Main Results:
- Overall survival at 8 years was similar between groups (87% ± 8% vs. 92% ± 3%, P=0.23).
- Freedom from reoperation was also similar (P=1.0).
- The prevalence of severe MR (≥3+) was significantly higher in the suboptimal repair group (15.6% vs. 2.1%, P<0.001), along with increased medication use. Even optimal repairs showed MR progression over time.
Conclusions:
- Mitral repair with residual MR >1+ is linked to reduced long-term durability and increased medical therapy needs.
- Optimal initial mitral repair results do not prevent the progression of degenerative MR.
- Continuous monitoring and management are essential even after successful mitral valve repair.
Related Concept Videos
Mitral Stenosis III: Medical Management
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral Regurgitation III: Medical Management
Mitral Regurgitation I: Introduction
Mitral Valve Prolapse II: Assessment and Management
Mitral Regurgitation II: Clinical Features and Diagnostic Tests

